Showing results (2191-2200 of 2,317) with videos related to

Sort By:
Pageof 232
Eclinicalmedicine|September 2, 2025
Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 studyJunning Cao, Guangliang Chen, Lihua Qiu, et al.
The New England Journal of Medicine|November 22, 2019
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLCSuresh S Ramalingam, Johan Vansteenkiste, David Planchard, et al.
Cell Stem Cell|December 27, 2022
Decoding m6A RNA methylome identifies PRMT6-regulated lipid transport promoting AML stem cell maintenanceYing Cheng, Zhuying Gao, Tiantian Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2018
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients WithShukui Qin, Jin Li, Liwei Wang, et al.
Nature Communications|March 14, 2026
Hepatocyte SLCO4C1 is a cAMP uptake transporter for inhibiting lipogenesis and a therapeutic target for MASLDXiaojia Huang, Sen Liang, Nan Zhao, et al.
The Journal of Infectious Diseases|March 2, 2023
Antibody Responses to the SARS-CoV-2 Ancestral Strain and Omicron Variants in Moderna mRNA-1273 Vaccinated Active-Duty US Navy Sailors and MarinesPeifang Sun, Corey A Balinsky, Le Jiang, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2023
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomesMartin Reck, Tudor-Eliade Ciuleanu, Manuel Cobo, et al.
Nucleic Acids Research|November 15, 2011
Major submissions tool developments at the European Nucleotide ArchiveClara Amid, Ewan Birney, Lawrence Bower, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2024
Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG StudyJin-Ji Yang, Yan Zhang, Lin Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2023
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURAJhanelle E Gray, Myung-Ju Ahn, Geoffrey R Oxnard, et al.
Pageof 232